Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 26;13(8):e237305.
doi: 10.1136/bcr-2020-237305.

Retinal vasoproliferative tumour-induced intractable neovascular glaucoma in a child with neurofibromatosis type 1

Deepika C Parameswarappa  1 , Abhilasha Arvind Alone  2 , Padmaja Kumari Rani  3
Affiliations
Case Reports

Retinal vasoproliferative tumour-induced intractable neovascular glaucoma in a child with neurofibromatosis type 1

Deepika C Parameswarappa et al. BMJ Case Rep. .
No abstract available

Keywords: glaucoma; iris; retina.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Both eyes iris surface showed pigmented nodular lesion (black arrows) suggestive of Lisch nodules. (A, B) Left eye (B) showed florid neovascularisation at the papillary margin and ectropion uveae (yellow arrow). Clinical photograph (C) showing upper chest and abdomen with multiple flat pigmented lesions characteristic of cafe-au-lait spots. (D) Magnified view.
Figure 2
Figure 2
Left eye fundus (A) showed an intreretinal elevated mass lesion in the inferior quadrant with dilated and tortuous vessels overlying the surface (black arrow) with subretinal and intraretinal exudations (white arrows). Ultrasound B-scan examination of the left eye (B) showed a medium echogenic retinal mass lesion (white arrow) with no calcification.
See this image and copyright information in PMC

References

    1. National Institutes of Health Consensus Development Conference Statement Neurofibromatosis. Arch Neurol 1988;45:575–8. 10.1001/archneur.1988.00520290115023 - DOI - PubMed
    1. Ferner RE, Huson SM, Thomas N, et al. . Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44:81–8. 10.1136/jmg.2006.045906 - DOI - PMC - PubMed
    1. Abdolrahimzadeh B, Piraino DC, Albanese G, et al. . Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography. Clin Ophthalmol 2016;10:851. 10.2147/OPTH.S102830 - DOI - PMC - PubMed
    1. Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol 2018;63:518–33. 10.1016/j.survophthal.2017.10.007 - DOI - PubMed
    1. Shields CL, Kaliki S, Al-Dahmash S, et al. . Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases. JAMA Ophthalmol 2013;131:328–34. 10.1001/2013.jamaophthalmol.524 - DOI - PubMed

Publication types